William Woodward

Executive Officer, Director at ImmunoVec.

Raised on ImmunoVec filings

$12.7M

of $15M offered across 1 Form D filing

Company

Biotech · Los Angeles, CA

DNA medicines that engineer immune cells inside the body

DNA medicines that engineer immune cells inside the body

ImmunoVec Form D filings
Filed	Security	Sold of offered	Filing
Jul 14, 2026	Equity	$12.7M/ $15M	Form D

Also named on ImmunoVec filings